The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review
Open accessAbstract
Background and Objectives: Chronic obstructive pulmonary disease (COPD) affects over 250 million people globally, carrying a notable economic burden. This systematic literature review aimed to highlight the economic burden associated with moderate-to-very severe COPD and to investigate key drivers of healthcare resource utilization (HRU), direct costs and indirect costs for this patient population. Materials and Methods: Relevant publications published between January 1, 2006 and November 14, 2016 were captured from the Embase, MEDLINE and MEDLINE In-Process databases. Supplemental searches from relevant 2015-2016 conferences were also performed. Titles and abstracts were reviewed by two independent researchers against pre-defined inclusion and exclusion criteria. Studies were grouped by the type of economic outcome presented (HRU or costs). Where possible, data were also grouped according to COPD severity and/or patient exacerbation history. Results: In total, 73 primary publications were included in this review: 66 reported HRU, 22 reported direct costs and one reported indirect costs. Most of the studies (94%) reported on data from either Europe or North America. Trends were noted across multiple studies for higher direct costs (including mean costs per patient per year and mean costs per exacerbation) being associated with increasingly severe COPD and/or a history of more frequent or severe exacerbations. Similar trends were noted according to COPD severity and/or exacerbation history for rate of hospitalization and primary care visits. Multivariate analyses were reported by 29 studies and demonstrated the statistical significance of these associations. Several other drivers of increased costs and HRU were highlighted for patients with moderate-to-very severe COPD, including comorbidities, and treatment history. Conclusion: Moderate-to-very severe COPD represents a considerable economic burden for healthcare providers despite the availability of efficacious treatments and comprehensive guidelines on their use. Further research is warranted to ensure cost-efficient COPD management, to improve treatments and ease budgetary pressures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Rahman, M. M., & Siddiqui, M. M. R. (2017) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v7i1.31596 · Cited by 3,106
Global and regional estimates of COPD prevalence: Systematic review and meta–analysis
Adeloye, D., Chua, S., Lee, C., Basquill, C., Papana, A., Theodoratou, E., Nair, H., Gasevic, D., Sridhar, D., Campbell, H., et al. (2015) · Journal of Global Health · doi:10.7189/jogh.05.020415 · Cited by 1,264
Suissa, S., Dell'Aniello, S., & Ernst, P. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201518 · Cited by 779
International Journal of Chronic Obstructive Pulmonary Disease
(2020) · International Journal of COPD · doi:10.2147/copd · Cited by 722
The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Ray, S., Guarascio, Finch, & Self, T. (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s34321 · Cited by 425
Ford, E. S., Murphy, L. B., Khavjou, O., Giles, W. H., Holt, J. B., & Croft, J. B. (2015) · Chest · doi:10.1378/chest.14-0972 · Cited by 353
Predictors of Rehospitalization and Death After a Severe Exacerbation of COPD
McGhan, R., Radcliff, T., Fish, R., Sutherland, E. R., Welsh, C., & Make, B. (2007) · Chest · doi:10.1378/chest.06-3018 · Cited by 282
The cost of moderate and severe COPD exacerbations to the Canadian healthcare system
Mittmann, N., Kuramoto, L., Seung, S. J., Haddon, J. M., Bradley-Kennedy, C., & FitzGerald, J. M. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.010 · Cited by 212
Economic Burden of COPD in the Presence of Comorbidities
Mannino, D. M., Higuchi, K., Yu, T.-C., Zhou, H., Li, Y., Tian, H., & Suh, K. (2015) · Chest · doi:10.1378/chest.14-2434 · Cited by 210
Lindenauer, P. K., Pekow, P., Gao, S., Crawford, A. S., Gutierrez, B., & Benjamin, E. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00006 · Cited by 190
Lung function impairment, COPD hospitalisations and subsequent mortality
Garcia-Aymerich, J., Serra Pons, I., Mannino, D. M., Maas, A. K., Miller, D. P., & Davis, K. J. (2011) · Thorax · doi:10.1136/thx.2010.152876 · Cited by 183
Garrido, P. C., Díez, J. D. M., Gutiérrez, J. R., Centeno, A. M., Vázquez, E. G., de Miguel, Á. G., Carballo, M. G., & García, R. J. (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-31 · Cited by 174
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries
Foo, J., Landis, S. H., Maskell, J., Oh, Y.-M., van der Molen, T., Han, M. K., Mannino, D. M., Ichinose, M., & Punekar, Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152618 · Cited by 169
Pasquale, M., Sun, Song, Hartnett, & Stemkowski (2012) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s36997 · Cited by 167
Physical Activity and Its Determinants in Severe Chronic Obstructive Pulmonary Disease
García‐Aymerich, J., Félez, M. A., Escarrabill, J., Marrades, R. M., Morera, J., Elosúa, R., & Antó, J. M. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000142378.98039.58 · Cited by 143
Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation
Xu, J., Washko, G. R., Nakahira, K., Hatabu, H., Patel, A. S., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1574oc · Cited by 141
Wacker, M. E., Jörres, R. A., Karch, A., Wilke, S., Heinrich, J., Karrasch, S., Koch, A., Schulz, H., Watz, H., Leidl, R., et al. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0238-9 · Cited by 128
COPD-related Bronchiectasis; Independent Impact on Disease Course and Outcomes
Gatheral, T. L., Kumar, N., Sansom, B., Lai, D., Nair, A., Vlahos, I., & Baker, E. H. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.922174 · Cited by 125
Brindicci, C., Kharitonov, S. A., Ito, M., Elliott, M. W., Hogg, J. C., Barnes, P. J., & Ito, K. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0493oc · Cited by 115
Wang, Q., & Bourbeau, J. (2005) · Respirology · doi:10.1111/j.1440-1843.2005.00718.x · Cited by 113
COPD management costs according to the frequency of COPD exacerbations in UK primary care
Punekar, Y. S., Shukla, A., & Müllerová, H. (2014) · International Journal of COPD · doi:10.2147/copd.s54417 · Cited by 107
Statin Use and Risk of Delirium in the Critically Ill
Page, V. J., Davis, D. H. J., Zhao, X. B., Norton, S., Casarin, A., Brown, T., Ely, E. W., & McAuley, D. F. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1150oc · Cited by 101
Matković, Z., Huerta, A. H., Soler, N., Domingo, R., Gabarrús, A., Torres, A., & Miravitlles, M. (2012) · Respiration · doi:10.1159/000335467 · Cited by 100
Blasi, F., Cesana, G., Conti, S., Chiodini, V., Aliberti, S., Fornari, C., & Mantovani, L. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101228 · Cited by 92
Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease
Dalal, A. A., Shah, M. B., Lunacsek, O., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.04.005 · Cited by 90
Bustamante‐Fermosel, A., de Miguel-Yanes, J. M., Falcó, M. D., & Muñoz, J. (2007) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2006.09.014 · Cited by 87
Mapel, D. W., Dutro, M. P., Marton, J. P., Woodruff, K., & Make, B. J. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-43 · Cited by 85
Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
Page, C. P., & Cazzola, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00003814 · Cited by 73
Sexual Dysfunction in Men with COPD: Impact on Quality of Life and Survival
Collins, E. G., Halabi, S., Langston, M., Schnell, T., Tobin, M. J., & Laghi, F. A. (2012) · Lung · doi:10.1007/s00408-012-9398-4 · Cited by 68
Stefan, M. S., Shieh, M., Pekow, P. S., Hill, N. S., Rothberg, M. B., & Lindenauer, P. K. (2014) · CHEST Journal · doi:10.1378/chest.14-1216 · Cited by 67
Miravitlles, M., Rubio, M. C., Gutiérrez, F. J. Á., Gobartt, E., López, F., & Martín, A. (2006) · Quality of Life Research · doi:10.1007/s11136-005-3215-y · Cited by 67
Srivastava, K., Thakur, D., Sharma, S., & Punekar, Y. S. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0252-4 · Cited by 63
Co-morbidities and 90-day Outcomes in Hospitalized COPD Exacerbations
Roberts, C. M., Stone, R. A., Lowe, D., Pursey, N. A., & Buckingham, R. J. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.600362 · Cited by 63
Yeo, J., Karimova, G., & Bansal, S. (2005) · Age and Ageing · doi:10.1093/ageing/afj002 · Cited by 61
Benzo, R. P., Kirsch, J. L., Dulohery, M. M., & Abascal-Bolado, B. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-490oc · Cited by 60
Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis
Yu, A. P., Yang, H., Wu, E. Q., et al. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.576295 · Cited by 55
Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
Huber, M. B., Wacker, M. E., Vogelmeier, C. F., & Leidl, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123292 · Cited by 54
Pretto, J. J., McDonald, V. M., Wark, P. A. B., & Hensley, M. J. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02475.x · Cited by 53
Løkke, A., Ulrik, C. S., Dahl, R., Plauborg, L., Dollerup, J., Cederkvist, L., Cording, P. H., & Dehlendorff, C. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.685118 · Cited by 52
FitzGerald, J. M., Haddon, J. M., Bradley-Kennedy, C., Kuramoto, L., Ford, G. T., & The RUSIC Study Group (2007) · Canadian Respiratory Journal · doi:10.1155/2007/921914 · Cited by 50
Factors associated with high healthcare resource utilisation among COPD patients
García-Polo, C., Navarrete, B. A., Ruiz, L. A., Herrejón, A., Ros, J. A., García-Sidro, P., Tirado-Conde, G., López-Campos, J. L., Martínez‐Rivera, C., Costán, J., et al. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.09.009 · Cited by 47
de Miguel‐Díez, J., Carrasco‐Garrido, P., Rejas, J., Centeno, A. M., Gobartt, E., Hernández‐Barrera, V., de Miguel, Á. G., & Jiménez‐García, R. (2010) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-10-8 · Cited by 46
Health-related quality of life in outpatients with COPD in daily practice: the VICE Spanish study
Martín, A. (2008) · International Journal of COPD · doi:10.2147/copd.s4791 · Cited by 39
Diastolic Dysfunction and COPD Exacerbation
Abusaid, G. H., Barbagelata, A., Tuero, E., Mahmood, A., & Sharma, G. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.07.2033 · Cited by 36
Gallego, M., Pomares, X., Capilla, S., Marcos, M. Á., Suarez, D. L., Monsó, E., & Montón, C. (2016) · International Journal of COPD · doi:10.2147/copd.s117129 · Cited by 35
Vitacca, M., Escarrabill, J., Galavotti, G., Vianello, A., Prats, E., Scala, R., Peratoner, A., Guffanti, E. E., Maggi, L., Barbano, L., et al. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2007.485 · Cited by 34
Oxygen Therapy Use in Older Adults with Chronic Obstructive Pulmonary Disease
Nishi, S. P. E., Zhang, W., Kuo, Y., & Sharma, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120684 · Cited by 34
Hospitalizations for COPD Exacerbations: Trends and Determinants of Death.
Molinari, N., Briand, C., Vachier, I., Malafaye, N., Aubas, P., Georgescu, V., Roche, N., Chanez, P., & BOURDIN, A. A. (2015) · PubMed · doi:10.3109/15412555.2015.1007931 · Cited by 33
AbuDagga, A., Sun, Tan, �., & Solem, C. T. (2013) · International Journal of COPD · doi:10.2147/copd.s40437 · Cited by 32
Gavazzi, A., Maria, R. D., Manzoli, L., Bocconcelli, P., Leonardo, A. D., Frigerio, M., Gasparini, S., Humar, F., Perna, G., Pozzi, R., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.056 · Cited by 31
Stanford, R. H., Shen, Y., & McLaughlin, T. P. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605050-00005 · Cited by 30
Punekar, Y. S., Müllerová, H., Small, M., Holbrook, T., Wood, R. P., Naya, I. P., & Valle, M. (2016) · Pulmonary Therapy · doi:10.1007/s41030-016-0011-5 · Cited by 30
Dhamane, A., Witt, E., & Su, J. (2016) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000735 · Cited by 29
Vallabhajosyula, S., Haddad, T. M., Sundaragiri, P. R., Ahmed, A., Nawaz, M. S., Rayes, H., Devineni, H. C., Kanmanthareddy, A., McCann, D. A., Wichman, C., et al. (2016) · Journal of Intensive Care Medicine · doi:10.1177/0885066616682232 · Cited by 27
Quintana, J. M., Esteban, C., García‐Gutiérrez, S., Aguirre, U., González, N., Lafuente, I., Baré, M., de Larrea, N. F., Rivas‐Ruiz, F., & for the IRYSS-COPD Group (2014) · Respiration · doi:10.1159/000365996 · Cited by 17
Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time
Esteban, C., Aróstegui, I., Aburto, M., Moraza, J., Quintana, J. M., García-Loizaga, A., Basualdo, L. V., Arámburu, A., Aizpiri, S., Uranga, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161710 · Cited by 17
Sharafkhaneh, A., Altan, A., Colice, G., Hanania, N. A., Donohue, J. F., Kurlander, J., Rodriguez‐Roisin, R., & Altman, P. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.07.002 · Cited by 15
Punekar, Y. S., Wurst, K., & Shukla, A. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.933953 · Cited by 15
GOLD severity stratification and risk of hospitalisation for COPD exacerbations
Lusuardi, M., Lucioni, C., Benedetto, F. D., Mazzi, S., Sanguinetti, C. M., & Donner, C. F. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2008.378 · Cited by 12
Vitacca, M., Bianchi, L. N. C., Bazza, A., & Clini, E. M. (2015) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2011.208 · Cited by 10
Prevalence and burden of dyspnoea among COPD patients in Japan
Small, M., Holbrook, T., Wood, R. P., Müllerová, H., Naya, I. P., & Punekar, Y. S. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12833 · Cited by 10
Cited by
Oxidative Stress in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2022) · Antioxidants · doi:10.3390/antiox11050965 · Cited by 281
El-Solh, A. A., Lawson, Y., & Wilding, G. E. (2023) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s430609 · Cited by 5
Metadata
- Authors
- Iheanacho, I., Zhang, S., King, D., Rizzo, M., & Ismaila, A. S.
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2020-02
- Volume
- Volume 15
- Pages
- 439-460
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- OpenAlex
- W3007745370
- Cited by
- 369
- References
- 66
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.